Related Experiment Videos
Models for empirical Bayes estimators of longitudinal CD4 counts
1Department of Epidemiology and Biostatistics, Boston University 02118, USA.
Statistics in Medicine
|November 15, 1996
Summary
This study compares two empirical Bayes estimators for CD4 T-cell count trajectories. Results show which model best corrects bias and improves Cox model predictions for clinical outcomes.
Area of Science:
- Biostatistics
- Immunology
- Epidemiology
Background:
- CD4 T-cell counts are crucial for monitoring HIV/AIDS progression.
- Measurement error in CD4 counts can bias clinical outcome predictions.
- Empirical Bayes methods can correct for bias in CD4 count estimations.
Purpose of the Study:
- To compare empirical Bayes estimators from random effects and stochastic regression models.
- To evaluate the performance of these estimators in Cox models for predicting clinical events.
- To assess bias correction capabilities for CD4 T-cell count trajectories.
Main Methods:
- Utilized empirical Bayes estimation techniques.
- Compared a random effects model with a general stochastic regression model.
- Applied Cox proportional hazards models to predict clinical outcomes.
- Analyzed data from the ACTG 118 study.
Main Results:
- Empirical Bayes estimates from the stochastic regression model demonstrated superior performance.
- The chosen model significantly impacted the accuracy of parameter estimates in Cox models.
- Bias correction for CD4 count trajectories was effectively achieved.
Conclusions:
- The stochastic regression model is recommended for empirical Bayes estimation of CD4 T-cell counts.
- Accurate CD4 count estimation is vital for reliable prediction of clinical outcomes in HIV research.
- Model selection critically influences the validity of CD4-based prognostic models.